For those of you who also call Indiana home, pharmaceutical giant Eli Lilly (LLY) has more than likely come across your radar on more than one occasion.
Being one of the largest employers based in the Hoosier state, Eli Lilly has certainly made its presence known to the local population over the years.
Now one of the world’s largest pharmaceutical companies, Eli Lilly has managed to make itself known much further than the borders of our midwestern state.
So, when news broke that this behemoth of a company looks to spend upwards of $1.8 billion U.S. to expand its manufacturing capacity over the course of the coming months, we in the manufacturing community should certainly take note. (Especially if you also call Indiana home!)
Today, let’s dive into the details of this breaking story and what it could mean for Eli Lilly, Indiana residents, and the overall manufacturing community.
Eli Lilly and Company, founded in 1876 by Colonel Eli Lilly in Indianapolis, Indiana, is one of the largest pharmaceutical companies in the world.
Colonel Lilly, a Civil War veteran and pharmacist, aimed to create high-quality medicines after witnessing the widespread use of ineffective and poorly prepared drugs.
The company introduced innovations in drug manufacturing, including using gelatin capsules and standardized dosages.
Throughout the 20th century, Eli Lilly grew rapidly by developing groundbreaking products, such as insulin for diabetes (1923), the polio vaccine (1950s), and the antidepressant Prozac (1987).
In recent years, Eli Lilly has focused on oncology, immunology, diabetes, and neuroscience treatments, continuing its legacy as one of the world’s powerhouse pharmaceutical service providers.
Now, when it comes to the company’s involvement in manufacturing, Eli Lilly’s manufacturing operations focus on producing high-quality pharmaceutical products through advanced technologies and strict regulatory compliance.
The company operates a global network of manufacturing facilities that produce medicines for various therapeutic areas, including diabetes, oncology, immunology, and neuroscience.
Eli Lilly emphasizes innovation in manufacturing processes, such as the use of continuous manufacturing systems, which improve efficiency and product consistency while following stringent quality control measures and Good Manufacturing Practices (GMP) to ensure the safety, purity, and efficacy of its products, adhering to international standards set by regulatory bodies like the FDA and EMA.
Recently, Eli Lilly representatives announced their plans to spend $1.8 billion U.S. to expand their manufacturing capacity to better meet global demand for their recently approved medications, for which demand has skyrocketed over the course of the last year, surpassing their current supply forcing the company to consider further expansion.
$1 billion of the allocated funds is expected to go to their Limerick Ireland facility to increase production of their Alzheimer’s treatment called “Kisunla”, while $800 million U.S. is to be used for the expansion of their Kinsale, Ireland facility where they produce their popular diabetes medication “Mounjaro” and their weight loss treatment “Zepbound.”
Eli Lilly has a significant global manufacturing presence, with facilities located across multiple continents to support its global pharmaceutical operations.
The company operates manufacturing plants in the United States, Latin America, Asia, and Europe, including Ireland, Italy, and Spain.
These facilities play a critical role in producing medicines for the European market and contribute to the company’s global supply chain, allowing it to produce and distribute medicines efficiently to meet worldwide demand.
… And while these investments are not in U.S. based facilities, Eli Lilly, being a U.S. based company will surely reap the benefits of this investment, allowing for its continued growth and the continued growth of the overall manufacturing sector.
You see, global manufacturing plays a critical role in strengthening U.S. manufacturing by fostering innovation, driving efficiency, and maintaining competitiveness in the global market and companies like Eli Lilly leverage their global manufacturing networks to adopt cutting-edge technologies and best practices from around the world, which they then implement in their U.S. facilities.
For instance, advancements in automation, continuous manufacturing, and quality control processes developed abroad can be integrated into domestic production lines, enhancing efficiency and product quality.
This cross-pollination of ideas and innovations ensures that U.S. manufacturing remains at the forefront of industry standards.
Furthermore, global manufacturing supports the health of U.S. operations by creating economies of scale that reduce production costs and allow for more focused specialization.
By distributing manufacturing processes across different countries, U.S. companies can focus their domestic facilities on producing high-value products, such as biologics or cutting-edge pharmaceuticals, while outsourcing more labor-intensive or resource-heavy manufacturing to countries with lower operational costs.
This strategic division allows U.S. plants to maximize efficiency and maintain competitiveness while ensuring that their global supply chains support the timely and cost-effective delivery of products.
… And let’s not forget, global manufacturing enhances the resilience and adaptability of U.S. operations.
With the ability to shift production between international and domestic plants in response to supply chain disruptions, companies can ensure continuity of production and protect against risks such as geopolitical instability, pandemics, or natural disasters.
This diversified manufacturing footprint enables U.S. companies to mitigate risks and safeguard their production capabilities, ultimately contributing to the long-term health and sustainability of U.S. manufacturing.
Eli Lilly’s $1.8 billion investment in expanding their manufacturing facilities in Ireland has significant implications for the global and U.S. manufacturing community, particularly for manufacturers with ties to Indiana.
This investment highlights the growing importance of global manufacturing networks, which allow companies to diversify production locations and meet rising international demand for pharmaceuticals.
For manufacturers in Indiana, this expansion could reinforce their role as a vital part of Eli Lilly’s global supply chain, creating opportunities for local businesses to collaborate on innovative solutions, supply materials, or develop complementary products that are essential to both U.S. and international markets while underscoring the need for maintaining competitiveness and innovation.
As Eli Lilly grows its international presence, it may increasingly rely on its Indiana operations to focus on high-value manufacturing processes, such as research and development, advanced biologics, or specialized drug production, potentially leading to increased investment in technology and workforce development within the state, as local manufacturers strive to keep pace with Eli Lilly’s global operations.
Additionally, Indiana facilities might also benefit from knowledge and best practices developed in Ireland, further enhancing the state’s role as a key player in Eli Lilly’s worldwide operations.
The investment highlights the interconnectedness of global manufacturing, where advancements or expansions abroad can influence strategic decisions in the U.S. market.
Indiana manufacturers with ties to Eli Lilly may see opportunities for partnership or collaboration in global ventures, allowing them to tap into international markets through Lilly’s expanded footprint.
… And while some production might shift abroad, this global growth can ultimately strengthen U.S. manufacturing by creating new opportunities for collaboration, innovation, and high-value production processes in Indiana.
Eli Lilly’s $1.8 billion investment in expanding its manufacturing facilities overseas signals a significant move towards enhancing its global manufacturing capabilities while presenting opportunities and challenges for the manufacturing community, particularly in Indiana.
As Eli Lilly continues to grow its international footprint, manufacturers in Indiana stand to benefit from increased collaboration, innovation, and the adoption of advanced technologies which is sure to underscore the importance of a global perspective in modern manufacturing, where operations in different regions contribute to the overall success of the industry.
… And for those of us who call the Hoosier state home, maintaining our role as key players in Eli Lilly’s global supply chain will require our continued innovation, workforce development, and strategic adaptation to an increasingly interconnected manufacturing landscape.
P.S. Does your manufacturing facility have more than 30 assets and counting?
Are you ready to take your growing business to the next level?
If you answered yes to these questions, then listen up!
You see, so far, you’ve done a great job of building your business into the success story it is today. Well done!
… But as time passes and you continue to grow, you and your team are going to find it increasingly more difficult to keep up with all the new responsibilities and issues that are sure to arise.
With as many assets as you currently have, you know better than anyone how full your workday can be. Now imagine those difficulties multiplied by two or three!
If that type of progression is something you are really interested in, then you’re going to need a reliable way to continue your growth while simplifying your workload.
Well, we here at Rain Engineering think we have just the solution to your problems. We call it Connectivity.
Connectivity is here to help you get the most out of your investments by connecting your technology, so all your data is housed in one place.
No longer will you be forced to run in circles around your facility collecting necessary data.
Facilities that invest in Connectivity have the power to collect and analyze valuable, real time system data from multiple sources in one centralized location, simplifying their integration process and providing an opportunity to catch time consuming issues before they gain momentum.
Here’s how it works:
Step 1: Schedule your shop floor assessment.
Step 2: Receive your custom plan for every asset
Step 3: Start using data to do better.
It’s as simple as that! No hassle, no major changes to your operating procedure.
… And it doesn’t matter how old your equipment is or what controller it currently has. Rain Engineering has successfully connected thousands of machines and can do the same for yours.
In a short period of time, you can have your entire plant giving all of the necessary data you need to successfully reach your business goals, allowing you to scale at a much faster rate than you ever dreamed!
Sound too good to be true? It isn’t. Not with Rain Engineering!
Folks, we understand the frustrations you face.
… And honestly, optimizing your shop floor doesn’t have to be as difficult as it might seem.
If the time has come and you’re really looking for ways to simplify your life while continuing to build your manufacturing business into the industry powerhouse you’ve always known it can be, we encourage you to check out Connectivity by Rain Engineering today!